Metric Snapshot
- Latest value
- 2.08x
- Coverage range
- 31 Oct 2010 - 31 Jan 2026
- Fact rows
- 62
Shareable Research Card
This metric view shows A - AGILENT TECHNOLOGIES, INC. current ratio history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
Latest period: Q4 2025. Period end: 31 Jan 2026. Units: x. Frequency: quarterly.
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Current Ratio levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Invesco CurrencyShares Australian Dollar Trust (["fxa"]) | 2,984.55x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Australian Dollar Trust Current Ratio |
| 2 | Invesco CurrencyShares British Pound Sterling Trust (["fxb"]) | 2,934.36x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares British Pound Sterling Trust Current Ratio |
| 3 | Invesco CurrencyShares Japanese Yen Trust (["fxy"]) | 2,057.85x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Japanese Yen Trust Current Ratio |
| 4 | Invesco CurrencyShares Swiss Franc Trust (["fxf"]) | 1,012.45x | Instant - 31 Mar 2019 | Open Invesco CurrencyShares Swiss Franc Trust Current Ratio |
| 5 | STARRY SEA ACQUISITION CORP (["ssea", "ssear", "sseau"]) | 690.21x | Instant - 31 Dec 2025 | Open STARRY SEA ACQUISITION CORP Current Ratio |
| 6 | Anbio Biotechnology (["nnnn"]) | 344.31x | Instant - 31 Dec 2025 | Open Anbio Biotechnology Current Ratio |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 2.08x | +0.05x | +2.2% | 31 Jan 2026 |
| Q3 2025 | 2.11x | -0.02x | -0.87% | 31 Oct 2025 |
| Q2 2025 | 2.16x | -0.09x | -4% | 31 Jul 2025 |
| Q1 2025 | 2.02x | -0.39x | -16% | 30 Apr 2025 |
| Q4 2024 | 2.04x | -0.45x | -18% | 31 Jan 2025 |
| Q3 2024 | 2.13x | -0.2x | -8.6% | 31 Oct 2024 |
| Q2 2024 | 2.24x | +0.05x | +2.4% | 31 Jul 2024 |
| Q1 2024 | 2.42x | +0.31x | +15% | 30 Apr 2024 |
| Q4 2023 | 2.48x | +0.46x | +23% | 31 Jan 2024 |
| Q3 2023 | 2.33x | +0.3x | +14% | 31 Oct 2023 |
| Q2 2023 | 2.19x | +0.11x | +5.2% | 31 Jul 2023 |
| Q1 2023 | 2.1x | -0.03x | -1.2% | 30 Apr 2023 |
| Q4 2022 | 2.02x | -0.11x | -5% | 31 Jan 2023 |
| Q3 2022 | 2.04x | -0.06x | -2.9% | 31 Oct 2022 |
| Q2 2022 | 2.08x | -0.03x | -1.5% | 31 Jul 2022 |
| Q1 2022 | 2.13x | -0.06x | -2.9% | 30 Apr 2022 |
| Q4 2021 | 2.13x | +0.05x | +2.5% | 31 Jan 2022 |
| Q3 2021 | 2.1x | +0.14x | +7.4% | 31 Oct 2021 |
| Q2 2021 | 2.12x | +0.36x | +20% | 31 Jul 2021 |
| Q1 2021 | 2.19x | +0.48x | +28% | 30 Apr 2021 |
| Q4 2020 | 2.08x | +0.06x | +2.8% | 31 Jan 2021 |
| Q3 2020 | 1.95x | -0.44x | -18% | 31 Oct 2020 |
| Q2 2020 | 1.76x | -1.2x | -41% | 31 Jul 2020 |
| Q1 2020 | 1.71x | -1.71x | -50% | 30 Apr 2020 |
| Q4 2019 | 2.02x | -1.37x | -40% | 31 Jan 2020 |
| Q3 2019 | 2.4x | -0.95x | -28% | 31 Oct 2019 |
| Q2 2019 | 2.96x | -0.39x | -12% | 31 Jul 2019 |
| Q1 2019 | 3.42x | +0.15x | +4.7% | 30 Apr 2019 |
| Q4 2018 | 3.39x | +0.15x | +4.7% | 31 Jan 2019 |
| Q3 2018 | 3.35x | +0.08x | +2.6% | 31 Oct 2018 |
| Q2 2018 | 3.35x | -0.03x | -0.8% | 31 Jul 2018 |
| Q1 2018 | 3.27x | -0.07x | -2.2% | 30 Apr 2018 |
| Q4 2017 | 3.24x | -0.07x | -2.1% | 31 Jan 2018 |
| Q3 2017 | 3.26x | -0.1x | -3% | 31 Oct 2017 |
| Q2 2017 | 3.38x | +0.02x | +0.72% | 31 Jul 2017 |
| Q1 2017 | 3.34x | -0.26x | -7.1% | 30 Apr 2017 |
| Q4 2016 | 3.31x | -0.52x | -14% | 31 Jan 2017 |
| Q3 2016 | 3.36x | -0.55x | -14% | 31 Oct 2016 |
| Q2 2016 | 3.35x | -0.34x | -9.2% | 31 Jul 2016 |
| Q1 2016 | 3.59x | +0.16x | +4.7% | 30 Apr 2016 |
| Q4 2015 | 3.83x | +0.55x | +17% | 31 Jan 2016 |
| Q3 2015 | 3.92x | +0.74x | +23% | 31 Oct 2015 |
| Q2 2015 | 3.69x | +0.55x | +18% | 31 Jul 2015 |
| Q1 2015 | 3.43x | +0.32x | +10% | 30 Apr 2015 |
| Q4 2014 | 3.27x | +0.33x | +11% | 31 Jan 2015 |
| Q3 2014 | 3.18x | +0.41x | +15% | 31 Oct 2014 |
| Q2 2014 | 3.14x | +0.54x | +21% | 31 Jul 2014 |
| Q1 2014 | 3.12x | +0.74x | +31% | 30 Apr 2014 |
| Q4 2013 | 2.94x | +0.39x | +15% | 31 Jan 2014 |
| Q3 2013 | 2.77x | +0.03x | +1.2% | 31 Oct 2013 |
| Q2 2013 | 2.6x | -0.28x | -9.6% | 31 Jul 2013 |
| Q1 2013 | 2.37x | -0.9x | -27% | 30 Apr 2013 |
| Q4 2012 | 2.55x | -0.7x | -22% | 31 Jan 2013 |
| Q3 2012 | 2.73x | -0.5x | -15% | 31 Oct 2012 |
| Q2 2012 | 2.88x | +0.1x | +3.6% | 31 Jul 2012 |
| Q1 2012 | 3.27x | +0.87x | +36% | 30 Apr 2012 |
| Q4 2011 | 3.25x | +1.06x | +48% | 31 Jan 2012 |
| Q3 2011 | 3.23x | +1.18x | +57% | 31 Oct 2011 |
| Q2 2011 | 2.78x | 31 Jul 2011 | ||
| Q1 2011 | 2.4x | 30 Apr 2011 | ||
| Q4 2010 | 2.2x | 31 Jan 2011 | ||
| Q3 2010 | 2.06x | 31 Oct 2010 |